Junbiao Wu

1.2k total citations
35 papers, 969 citations indexed

About

Junbiao Wu is a scholar working on Nephrology, Molecular Biology and Epidemiology. According to data from OpenAlex, Junbiao Wu has authored 35 papers receiving a total of 969 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Nephrology, 13 papers in Molecular Biology and 8 papers in Epidemiology. Recurrent topics in Junbiao Wu's work include Renal Diseases and Glomerulopathies (13 papers), Chronic Kidney Disease and Diabetes (9 papers) and Autophagy in Disease and Therapy (6 papers). Junbiao Wu is often cited by papers focused on Renal Diseases and Glomerulopathies (13 papers), Chronic Kidney Disease and Diabetes (9 papers) and Autophagy in Disease and Therapy (6 papers). Junbiao Wu collaborates with scholars based in China, United Kingdom and United States. Junbiao Wu's co-authors include Jiuyao Zhou, Bihao Liu, Ruirui Lu, Chun-Ling Liang, Junqi Chen, Peichun Zhang, Yu Pang, Ji‐Cheng Li, Yuan Zhou and Dandan Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Food Chemistry and Biochemical Pharmacology.

In The Last Decade

Junbiao Wu

35 papers receiving 963 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junbiao Wu China 22 413 333 128 108 102 35 969
Xinyan Chen China 16 412 1.0× 203 0.6× 90 0.7× 57 0.5× 54 0.5× 81 999
Ruizhi Tan China 21 716 1.7× 340 1.0× 133 1.0× 188 1.7× 133 1.3× 73 1.4k
Prajjal K. Singha United States 14 521 1.3× 216 0.6× 77 0.6× 83 0.8× 99 1.0× 19 1.1k
Zhilei Wang China 19 654 1.6× 171 0.5× 186 1.5× 179 1.7× 259 2.5× 43 1.1k
Yessica Zamudio‐Cuevas Mexico 16 368 0.9× 277 0.8× 51 0.4× 75 0.7× 76 0.7× 52 834
Jau‐Shyang Huang Taiwan 20 416 1.0× 210 0.6× 53 0.4× 90 0.8× 46 0.5× 35 1.1k
Yonger Chen China 14 287 0.7× 116 0.3× 74 0.6× 70 0.6× 124 1.2× 20 609
Hui Lin China 22 642 1.6× 122 0.4× 154 1.2× 113 1.0× 40 0.4× 73 1.4k
Zheng Xu China 18 488 1.2× 114 0.3× 141 1.1× 217 2.0× 45 0.4× 35 1.1k
Fang Zhong China 19 417 1.0× 292 0.9× 58 0.5× 100 0.9× 31 0.3× 47 900

Countries citing papers authored by Junbiao Wu

Since Specialization
Citations

This map shows the geographic impact of Junbiao Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junbiao Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junbiao Wu more than expected).

Fields of papers citing papers by Junbiao Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junbiao Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junbiao Wu. The network helps show where Junbiao Wu may publish in the future.

Co-authorship network of co-authors of Junbiao Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Junbiao Wu. A scholar is included among the top collaborators of Junbiao Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junbiao Wu. Junbiao Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Yiwen, Huan Zhao, Junqi Chen, et al.. (2025). Danshen injection ameliorates unilateral ureteral obstruction-induced renal fibrosis by inhibiting ferroptosis via activating SIRT1/GPX4 pathway. Frontiers in Pharmacology. 15. 1503628–1503628. 1 indexed citations
2.
Wang, Huanhuan, Xiaojie Li, Hongmei Zhang, et al.. (2025). Niao-Du-Kang granules regulate autophagy of diabetic nephropathy via the miR-214-3p/SIRT1 signaling pathway. Journal of Ethnopharmacology. 352. 120175–120175. 1 indexed citations
3.
Huang, Fei, Qiaoxuan Zhang, Junbiao Wu, et al.. (2024). Identification of mitochondria-related genes as diagnostic biomarkers for diabetic nephropathy and their correlation with immune infiltration: New insights from bioinformatics analysis. International Immunopharmacology. 142(Pt A). 113114–113114. 4 indexed citations
4.
Liang, Chun-Ling, Yuchao Chen, Huazhen Liu, et al.. (2024). Zhen-Wu-Tang ameliorates lupus nephritis by diminishing renal tissue-resident memory CD8+ T cells via suppressing IL-15/STAT3 pathway. Biomedicine & Pharmacotherapy. 174. 116597–116597. 5 indexed citations
5.
Liu, Yaoyu, Xiaojie Li, Yifan Wu, et al.. (2023). Macrophage-derived exosomes promote activation of NLRP3 inflammasome and autophagy deficiency of mesangial cells in diabetic nephropathy. Life Sciences. 330. 121991–121991. 31 indexed citations
6.
Chen, Dandan, Junqi Chen, Hua Lin, et al.. (2021). JAK/STAT pathway promotes the progression of diabetic kidney disease via autophagy in podocytes. European Journal of Pharmacology. 902. 174121–174121. 63 indexed citations
7.
Li, Honglian, Ruirui Lu, Yu Pang, et al.. (2020). Zhen-Wu-Tang Protects IgA Nephropathy in Rats by Regulating Exosomes to Inhibit NF-κB/NLRP3 Pathway. Frontiers in Pharmacology. 11. 1080–1080. 39 indexed citations
8.
Pang, Yu, Peichun Zhang, Ruirui Lu, et al.. (2020). Andrade-Oliveira Salvianolic Acid B Modulates Caspase-1–Mediated Pyroptosis in Renal Ischemia-Reperfusion Injury via Nrf2 Pathway. Frontiers in Pharmacology. 11. 541426–541426. 57 indexed citations
9.
He, Yu, Ruirui Lu, Junbiao Wu, et al.. (2020). Salvianolic acid B attenuates epithelial-mesenchymal transition in renal fibrosis rats through activating Sirt1-mediated autophagy. Biomedicine & Pharmacotherapy. 128. 110241–110241. 47 indexed citations
10.
Ling, Yan, Yiming Xu, Li G, et al.. (2019). Pseudogene DUXAP10 acts as a diagnostic and prognostic marker and promotes cell proliferation by activating PI3K/AKT pathway in hepatocellular carcinoma. SHILAP Revista de lepidopterología. 1 indexed citations
11.
Bai, Lixia, Ji‐Cheng Li, Honglian Li, et al.. (2019). Renoprotective effects of artemisinin and hydroxychloroquine combination therapy on IgA nephropathy via suppressing NF-κB signaling and NLRP3 inflammasome activation by exosomes in rats. Biochemical Pharmacology. 169. 113619–113619. 63 indexed citations
12.
Liu, Bihao, Lixia Bai, Yuan Zhou, et al.. (2019). Paeoniflorin Inhibits Mesangial Cell Proliferation and Inflammatory Response in Rats With Mesangial Proliferative Glomerulonephritis Through PI3K/AKT/GSK-3β Pathway. Frontiers in Pharmacology. 10. 978–978. 44 indexed citations
13.
Liu, Bihao, Ruirui Lu, Honglian Li, et al.. (2019). Zhen-wu-tang ameliorates membranous nephropathy rats through inhibiting NF-κB pathway and NLRP3 inflammasome. Phytomedicine. 59. 152913–152913. 51 indexed citations
14.
Bai, Lixia, Honglian Li, Ji‐Cheng Li, et al.. (2019). Immunosuppressive effect of artemisinin and hydroxychloroquine combination therapy on IgA nephropathy via regulating the differentiation of CD4+ T cell subsets in rats. International Immunopharmacology. 70. 313–323. 35 indexed citations
15.
Liang, Chengyu, et al.. (2018). DcR3 induces proliferation, migration, invasion, and EMT in gastric cancer cells via the PI3K/AKT/GSK-3β/β-catenin signaling pathway. SHILAP Revista de lepidopterología. 1 indexed citations
16.
Liu, Bihao, Yu He, Ruirui Lu, et al.. (2018). Zhen-wu-tang protects against podocyte injury in rats with IgA nephropathy via PPARγ/NF-κB pathway. Biomedicine & Pharmacotherapy. 101. 635–647. 26 indexed citations
17.
Wu, Junbiao, Yuan Zhou, Chun-Ling Liang, et al.. (2016). Cyclovirobuxinum D alleviates cardiac hypertrophy in hyperthyroid rats by preventing apoptosis of cardiac cells and inhibiting the p38 mitogen-activated protein kinase signaling pathway. Chinese Journal of Integrative Medicine. 23(10). 770–778. 23 indexed citations
18.
Wu, Junbiao, Bihao Liu, Chun-Ling Liang, et al.. (2016). Zhen-wu-tang attenuates cationic bovine serum albumin-induced inflammatory response in membranous glomerulonephritis rat through inhibiting AGEs/RAGE/NF-κB pathway activation. International Immunopharmacology. 33. 33–41. 39 indexed citations
19.
Liang, Chun-Ling, Junbiao Wu, Jin Lin, et al.. (2014). Protection Effect of Zhen‐Wu‐Tang on Adriamycin‐Induced Nephrotic Syndrome via Inhibiting Oxidative Lesions and Inflammation Damage. Evidence-based Complementary and Alternative Medicine. 2014(1). 131604–131604. 33 indexed citations
20.
Wu, Junbiao. (2012). Therapeutic Effect of Zhenwu Decoction on Chronic Glomerulonephritis Rat Model Induced by Cationization Bovine Serum Albumin Osmotic Pump. Traditional Chinese Drug Research and Clinical Pharmacology. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xinyan Chen Breakdown of academic impact, for papers by Ruizhi Tan Breakdown of academic impact, for papers by Prajjal K. Singha Breakdown of academic impact, for papers by Zhilei Wang Breakdown of academic impact, for papers by Yessica Zamudio‐Cuevas Breakdown of academic impact, for papers by Jau‐Shyang Huang Breakdown of academic impact, for papers by Yonger Chen Breakdown of academic impact, for papers by Hui Lin Breakdown of academic impact, for papers by Zheng Xu Breakdown of academic impact, for papers by Fang Zhong
Rankless by CCL
2026